TrialPharmacogenetics and genomics2010

DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia.

Todd Lencz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.